QDOT MICRO System
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QDOT MICRO System, covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.